227 related articles for article (PubMed ID: 18458136)
41. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
[TBL] [Abstract][Full Text] [Related]
42. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Laverdiere M; Hoban D; Restieri C; Habel F
J Antimicrob Chemother; 2002 Jul; 50(1):119-23. PubMed ID: 12096017
[TBL] [Abstract][Full Text] [Related]
43. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
44. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
45. In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Eksi F; Gayyurhan ED; Balci I
ScientificWorldJournal; 2013; 2013():236903. PubMed ID: 24250260
[TBL] [Abstract][Full Text] [Related]
46. Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.
Castanheira M; Woosley LN; Messer SA; Diekema DJ; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2014; 58(1):577-80. PubMed ID: 24126582
[TBL] [Abstract][Full Text] [Related]
47. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.
Beyda ND; Liao G; Endres BT; Lewis RE; Garey KW
Antimicrob Agents Chemother; 2015 Sep; 59(9):5405-12. PubMed ID: 26100700
[TBL] [Abstract][Full Text] [Related]
48. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
[TBL] [Abstract][Full Text] [Related]
49. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
Yang YL; Chen HT; Lin CC; Chu WL; Lo HJ;
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):182-6. PubMed ID: 23574935
[TBL] [Abstract][Full Text] [Related]
50. EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
Mycoses; 2014 Jun; 57(6):377-9. PubMed ID: 24417759
[TBL] [Abstract][Full Text] [Related]
51. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Posteraro B; Martucci R; La Sorda M; Fiori B; Sanglard D; De Carolis E; Florio AR; Fadda G; Sanguinetti M
J Clin Microbiol; 2009 Jun; 47(6):1927-30. PubMed ID: 19403774
[TBL] [Abstract][Full Text] [Related]
52. Biguanides enhance antifungal activity against Candida glabrata.
Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
[TBL] [Abstract][Full Text] [Related]
53. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
[TBL] [Abstract][Full Text] [Related]
54. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
[TBL] [Abstract][Full Text] [Related]
55. Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.
Schell WA; Jones AM; Borroto-Esoda K; Alexander BD
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827419
[TBL] [Abstract][Full Text] [Related]
56. Spontaneous Mutational Frequency and
Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
[TBL] [Abstract][Full Text] [Related]
57. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Monzón A; Rodríguez-Tudela JL
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):432-5. PubMed ID: 10442422
[TBL] [Abstract][Full Text] [Related]
58. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Marco F; Danés C; Almela M; Jurado A; Mensa J; de la Bellacasa JP; Espasa M; Martínez JA; Jiménez de Anta MT
Diagn Microbiol Infect Dis; 2003 Aug; 46(4):259-64. PubMed ID: 12944017
[TBL] [Abstract][Full Text] [Related]
59. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
60. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Pfaller MA; Messer SA; Gee S; Joly S; Pujol C; Sullivan DJ; Coleman DC; Soll DR
J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
